发明名称 Vaccine
摘要 Vaccine comprising a peptide bound to a pharmaceutically acceptable carrier, said peptide having the amino acid sequence;(Formula I)(SEQ ID NO: 1)(X1)m(X2)n(X3)oX4X5HPX6,for treating and/or preventing a physical disorder associated with the renin-activated angiotensin system, wherein X1 is G or D,X2 is A, P, M, G, or R,X3 is G, A, H, or V, X4 is S, A, D, or Y,X5 is A, D, H, S, N, or I,X6 is A, L or F,wherein m, n and o are independently 0 or 1 under the premise that when o is 0 m and n are 0 and when n is 0 m is 0, and wherein the peptide is not DRVYIHPF (SEQ ID NO:4).
申请公布号 US9029327(B2) 申请公布日期 2015.05.12
申请号 US201013386603 申请日期 2010.07.23
申请人 Affiris AG 发明人 Staffler Günther;Lührs Petra;Mairhofer Andreas;Mattner Frank;Schmidt Walter;Dolischka Andrea
分类号 A61K38/55;A61K38/00;A61K38/08;A61K38/04;A61K39/385;A61K39/00;C07K14/435 主分类号 A61K38/55
代理机构 Nevrivy Patent Law Group P.L.L.C. 代理人 Nevrivy Patent Law Group P.L.L.C.
主权项 1. A pharmaceutical composition for inducing an immune response comprising a peptide bound to a pharmaceutically acceptable carrier, wherein said peptide comprises a sequence selected from the group consisting of DPVYIHPF (SEQ ID NO:7), DAVYIHPF (SEQ ID NO:10), DRHYIHPF (SEQ ID NO:13), DAAYIHPF (SEQ ID NO:27), DRAYAHPF (SEQ ID NO:30), DPGYIHPF (SEQ ID NO:39), DRAYDHPF (SEQ ID NO:58), AAYIHPF (SEQ ID NO: 111), RAYAHPF (SEQ ID NO: 114), PGYIHPF (SEQ ID NO:164), wherein the pharmaceutical composition for inducing an immune response is for treating a physical disorder associated with the renin-activated angiotensin system.
地址 Vienna AT
您可能感兴趣的专利